547 related articles for article (PubMed ID: 23994691)
1. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
2. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
3. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
5. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
[TBL] [Abstract][Full Text] [Related]
6. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
[TBL] [Abstract][Full Text] [Related]
7. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
Cavalieri EL; Rogan EG; Zahid M
Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
[TBL] [Abstract][Full Text] [Related]
8. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
Yager JD
Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
[TBL] [Abstract][Full Text] [Related]
10. Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.
Cavalieri EL; Rogan EG
Clin Transl Med; 2016 Mar; 5(1):12. PubMed ID: 26979321
[TBL] [Abstract][Full Text] [Related]
11. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.
Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019
[TBL] [Abstract][Full Text] [Related]
12. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.
Cavalieri EL; Rogan EG; Chakravarti D
Cell Mol Life Sci; 2002 Apr; 59(4):665-81. PubMed ID: 12022473
[TBL] [Abstract][Full Text] [Related]
13. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
[TBL] [Abstract][Full Text] [Related]
14. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
15. Etiology and prevention of prevalent types of cancer.
Cavalieri EL; Rogan EG
J Rare Dis Res Treat; 2017; 2(3):22-29. PubMed ID: 30854528
[TBL] [Abstract][Full Text] [Related]
16. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
Cavalieri EL; Stack DE; Devanesan PD; Todorovic R; Dwivedy I; Higginbotham S; Johansson SL; Patil KD; Gross ML; Gooden JK; Ramanathan R; Cerny RL; Rogan EG
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10937-42. PubMed ID: 9380738
[TBL] [Abstract][Full Text] [Related]
17. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity.
Saeed M; Zahid M; Gunselman SJ; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):29-35. PubMed ID: 15610894
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
[TBL] [Abstract][Full Text] [Related]
19. The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.
Chakravarti D; Venugopal D; Mailander PC; Meza JL; Higginbotham S; Cavalieri EL; Rogan EG
Mutat Res; 2008 Jan; 649(1-2):161-78. PubMed ID: 17931959
[TBL] [Abstract][Full Text] [Related]
20. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
